Clinical Trial: Phase 1 Study of KH607 Tablets

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393803) titled 'Phase 1 Study of KH607 Tablets' on Jan. 4.

Brief Summary: This study was a single-center, randomized, double-blind, placebo-controlled study divided into a Single Ascending Dose (SAD) stage and a Multiple Ascending Dose (MAD) stage. The primary objective was to evaluate the safety and tolerability of KH607 tablets in Chinese healthy volunteers.

Study Type: Interventional

Condition: Healthy

Intervention: * Drug: 2mg KH607 tablets

Subject receive KH607 tablets or placebo orally single dose.

* Drug: 5mg KH607 tablets

Subject receive KH607 tablets or placebo orally single dose.

* Drug: 10mg KH607 tablets

Subject receive KH607 tabl...